BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12480778)

  • 1. Hemodynamic aspects of Alzheimer's disease.
    Nagata K; Sato M; Satoh Y; Watahiki Y; Kondoh Y; Sugawara M; Box G; Wright D; Leung S; Yuya H; Shimosegawa E
    Ann N Y Acad Sci; 2002 Nov; 977():391-402. PubMed ID: 12480778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can PET data differentiate Alzheimer's disease from vascular dementia?
    Nagata K; Maruya H; Yuya H; Terashi H; Mito Y; Kato H; Sato M; Satoh Y; Watahiki Y; Hirata Y; Yokoyama E; Hatazawa J
    Ann N Y Acad Sci; 2000 Apr; 903():252-61. PubMed ID: 10818514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular and metabolic reserve in Alzheimer's disease.
    Nagata K; Kondoh Y; Atchison R; Sato M; Satoh Y; Watahiki Y; Hirata Y; Yokoyama E
    Neurobiol Aging; 2000; 21(2):301-7. PubMed ID: 10867215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misery perfusion with preserved vascular reactivity in Alzheimer's disease.
    Nagata K; Buchan RJ; Yokoyama E; Kondoh Y; Sato M; Terashi H; Satoh Y; Watahiki Y; Senova M; Hirata Y; Hatazawa J
    Ann N Y Acad Sci; 1997 Sep; 826():272-81. PubMed ID: 9329699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of calibrated fMRI in Alzheimer's disease.
    Lajoie I; Nugent S; Debacker C; Dyson K; Tancredi FB; Badhwar A; Belleville S; Deschaintre Y; Bellec P; Doyon J; Bocti C; Gauthier S; Arnold D; Kergoat MJ; Chertkow H; Monchi O; Hoge RD
    Neuroimage Clin; 2017; 15():348-358. PubMed ID: 28560160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies of cerebral blood flow and metabolism in patients with senile dementia of the Alzheimer's type and diagnostic evaluation of the dementing illnesses by positron emission tomography].
    Sakamoto S
    Nihon Ika Daigaku Zasshi; 1990 Jun; 57(3):222-34. PubMed ID: 2376611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional cerebral blood flow and cerebrovascular reactivity in Alzheimer's disease and vascular dementia assessed by arterial spinlabeling magnetic resonance imaging.
    Gao YZ; Zhang JJ; Liu H; Wu GY; Xiong L; Shu M
    Curr Neurovasc Res; 2013 Feb; 10(1):49-53. PubMed ID: 23151075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
    Mak HK; Chan Q; Zhang Z; Petersen ET; Qiu D; Zhang L; Yau KK; Chu LW; Golay X
    J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of cerebral blood flow in Alzheimer disease and vascular dementia.
    Yoshikawa T; Murase K; Oku N; Imaizumi M; Takasawa M; Rishu P; Kimura Y; Ikejiri Y; Kitagawa K; Hori M; Hatazawa J
    AJNR Am J Neuroradiol; 2003 Aug; 24(7):1341-7. PubMed ID: 12917125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular responsiveness to hypercapnia in Alzheimer's dementia and vascular dementia of the Binswanger type.
    Kuwabara Y; Ichiya Y; Otsuka M; Masuda K; Ichimiya A; Fujishima M
    Stroke; 1992 Apr; 23(4):594-8. PubMed ID: 1561693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease.
    de la Torre JC
    J Alzheimers Dis; 2012; 32(3):553-67. PubMed ID: 22842871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced blood oxygenation level dependent connectivity is related to hypoperfusion in Alzheimer's disease.
    Göttler J; Preibisch C; Riederer I; Pasquini L; Alexopoulos P; Bohn KP; Yakushev I; Beller E; Kaczmarz S; Zimmer C; Grimmer T; Drzezga A; Sorg C
    J Cereb Blood Flow Metab; 2019 Jul; 39(7):1314-1325. PubMed ID: 29431005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoreactivity induced by acetazolamide in patients with vascular dementia versus Alzheimer's disease.
    Likitjaroen Y; Suwanwela NC; Phanthumchinda K
    J Neurol Sci; 2009 Aug; 283(1-2):32-5. PubMed ID: 19375084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral hemodynamic evaluation using perfusion-weighted magnetic resonance imaging: comparison with positron emission tomography values in chronic occlusive carotid disease.
    Kajimoto K; Moriwaki H; Yamada N; Hayashida K; Kobayashi J; Miyashita K; Naritomi H
    Stroke; 2003 Jul; 34(7):1662-6. PubMed ID: 12791940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral blood flow patterns in Binswanger's disease: a SPECT study using three-dimensional stereotactic surface projections.
    Hanyu H; Shimuzu S; Tanaka Y; Takasaki M; Koizumi K; Abe K
    J Neurol Sci; 2004 May; 220(1-2):79-84. PubMed ID: 15140610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial and extracranial ultrasound assessment of cerebral hemodynamics in vascular and Alzheimer's dementia.
    Doepp F; Valdueza JM; Schreiber SJ
    Neurol Res; 2006 Sep; 28(6):645-9. PubMed ID: 16945217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonographic measurement of cerebral blood flow, cerebral circulation time and cerebral blood volume in vascular and Alzheimer's dementia.
    Schreiber SJ; Doepp F; Spruth E; Kopp UA; Valdueza JM
    J Neurol; 2005 Oct; 252(10):1171-7. PubMed ID: 16151603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cerebral blood flow and oxygen metabolism related to magnetic resonance imaging white matter hyperintensities in Alzheimer's disease.
    Yamaji S; Ishii K; Sasaki M; Imamura T; Kitagaki H; Sakamoto S; Mori E
    J Nucl Med; 1997 Sep; 38(9):1471-4. PubMed ID: 9293811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET.
    Ishii K; Kitagaki H; Kono M; Mori E
    J Nucl Med; 1996 Jul; 37(7):1159-65. PubMed ID: 8965188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.